DK0430045T3 - Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion - Google Patents

Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion

Info

Publication number: DK0430045T3
Authority: DK; Denmark
Prior art keywords: reaction; ethocopheryl; ascorbic acid; phosphate diesters; maillard
Prior art date: 1989-11-21

Application number

DK90122218.2T

Other languages

English (en)

Inventor

Jun Inoue

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-21

Filing date

1990-11-20

Publication date

1995-07-17

1990-11-20 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

1995-07-17 Application granted granted Critical

1995-07-17 Publication of DK0430045T3 publication Critical patent/DK0430045T3/da

Links

CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title 2
229910019142 PO4 Inorganic materials 0.000 title 1
229960005070 ascorbic acid Drugs 0.000 title 1
235000010323 ascorbic acid Nutrition 0.000 title 1
239000011668 ascorbic acid Substances 0.000 title 1
239000010452 phosphate Substances 0.000 title 1
-1 phosphate diesters Chemical class 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000002249 Diabetes Complications Diseases 0.000 abstract 1
206010012655 Diabetic complications Diseases 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

DK90122218.2T 1989-11-21 1990-11-20 Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion DK0430045T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP1304479A JP2854631B2 (ja)	1989-11-21	1989-11-21	糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤

Publications (1)

Publication Number	Publication Date
DK0430045T3 true DK0430045T3 (da)	1995-07-17

Family

ID=17933520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90122218.2T DK0430045T3 (da)	1989-11-21	1990-11-20	Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion

Country Status (8)

Country	Link
EP (1)	EP0430045B1 (da)
JP (1)	JP2854631B2 (da)
KR (1)	KR910009272A (da)
AT (1)	ATE121939T1 (da)
CA (1)	CA2029420C (da)
DE (1)	DE69019111T2 (da)
DK (1)	DK0430045T3 (da)
ES (1)	ES2071725T3 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05286848A (ja) *	1992-04-10	1993-11-02	Senju Pharmaceut Co Ltd	浴用剤
ES2179831T3 (es)	1992-09-29	2003-02-01	Inhale Therapeutic Syst	Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
CA2129509A1 (en) *	1993-09-10	1995-03-11	Kazumi Ogata	Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
NZ281112A (en)	1994-03-07	1998-04-27	Inhale Therapeutic Syst	Powdered insulin delivered as an aerosol
US5955448A (en) *	1994-08-19	1999-09-21	Quadrant Holdings Cambridge Limited	Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
GB2288732B (en) *	1994-04-13	1998-04-29	Quadrant Holdings Cambridge	Pharmaceutical compositions
JP3362501B2 (ja) *	1994-04-28	2003-01-07	千寿製薬株式会社	角膜障害治療剤
JP3396953B2 (ja) *	1994-05-10	2003-04-14	千寿製薬株式会社	網膜疾患予防・治療剤
JPH07330501A (ja)	1994-06-14	1995-12-19	Senju Pharmaceut Co Ltd	肝保存剤および肝保存方法
US6290991B1 (en)	1994-12-02	2001-09-18	Quandrant Holdings Cambridge Limited	Solid dose delivery vehicle and methods of making same
CA2152693A1 (en) *	1994-08-05	1996-02-06	Kazumi Ogata	Therapeutic composition for pancreatitis
US5795912A (en) *	1995-04-26	1998-08-18	Senju Pharmaceutical, Co., Ltd.	Therapeutic composition for corneal impairment
CA2179940A1 (en)	1995-07-18	1997-01-19	Kazumi Ogata	Antiallergic composition comprising a phosphoric diester compound
CA2186654A1 (en) *	1995-10-13	1997-04-14	Masayuki Nakamura	Phosphoric diester
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
WO1999039716A1 (en) *	1998-02-03	1999-08-12	Senju Pharmaceutical Co., Ltd.	Preventives and remedies for neuron digeneration-associated diseaseas
US8404217B2 (en)	2000-05-10	2013-03-26	Novartis Ag	Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ES2525087T5 (es)	2000-05-10	2018-06-28	Novartis Ag	Polvos basados en fosfolípidos para administración de fármacos
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AUPR549901A0 (en)	2001-06-06	2001-07-12	Vital Health Sciences Pty Ltd	Topical formulation containing tocopheryl phosphates
WO2003011303A1 (en)	2001-07-27	2003-02-13	Vital Health Sciences Pty Ltd	Dermal therapy using phosphate derivatives of electron transfer agents
AUPR684801A0 (en) *	2001-08-06	2001-08-30	Vital Health Sciences Pty Ltd	Supplement therapy
CA2458279A1 (en) *	2001-09-26	2003-04-03	Vital Health Sciences Pty Ltd.	Modulation of vitamin storage
JP2005514393A (ja)	2001-12-19	2005-05-19	ネクターセラピューティクス	アミノグリコシドの肺への供給
AU2002950713A0 (en)	2002-08-09	2002-09-12	Vital Health Sciences Pty Ltd	Carrier
DK1720551T3 (da)	2004-03-03	2011-05-16	Vital Health Sciences Pty Ltd	Alkaloidformuleringer
AU2006220248B2 (en) *	2005-03-03	2012-06-21	Vital Health Sciences Pty Ltd	Compounds having lipid lowering properties
NZ565049A (en)	2005-06-17	2012-02-24	Vital Health Sciences Pty Ltd	A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
ES2999020T3 (en)	2010-02-05	2025-02-24	Phosphagenics Ltd	Carrier comprising non-neutralised tocopheryl phosphate
EP2552486B1 (en)	2010-03-30	2020-08-12	Phosphagenics Limited	Transdermal delivery patch
WO2012122586A1 (en)	2011-03-15	2012-09-20	Phosphagenics Limited	New composition
CN104297412B (zh) *	2014-10-17	2015-12-02	徐州工程学院	一种蛋白粉新鲜度的测定方法
CN114712308A (zh)	2015-12-09	2022-07-08	磷肌酸有限公司	药物制剂
EP3558903B1 (en)	2016-12-21	2024-07-03	Avecho Biotechnology Limited	Process for phosphorylating a complex alcohol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59219295A (ja) *	1983-05-30	1984-12-10	Senjiyu Seiyaku Kk	リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) *	1986-03-04	1987-09-09	Senjiyu Seiyaku Kk	新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JP2546687B2 (ja) *	1987-09-11	1996-10-23	千寿製薬株式会社	リン酸ジエステルまたはその塩からなる抗酸化剤
PH25859A (en) *	1988-01-11	1991-12-02	Takeda Chemical Industries Ltd	Composition for treatment of ischemic disorder

1989
- 1989-11-21 JP JP1304479A patent/JP2854631B2/ja not_active Expired - Lifetime
1990
- 1990-11-07 CA CA002029420A patent/CA2029420C/en not_active Expired - Fee Related
- 1990-11-16 KR KR1019900018594A patent/KR910009272A/ko not_active Ceased
- 1990-11-20 ES ES90122218T patent/ES2071725T3/es not_active Expired - Lifetime
- 1990-11-20 DK DK90122218.2T patent/DK0430045T3/da active
- 1990-11-20 DE DE69019111T patent/DE69019111T2/de not_active Expired - Fee Related
- 1990-11-20 AT AT90122218T patent/ATE121939T1/de not_active IP Right Cessation
- 1990-11-20 EP EP90122218A patent/EP0430045B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0430045A3 (en)	1991-11-06
KR910009272A (ko)	1991-06-28
JPH03161444A (ja)	1991-07-11
DE69019111D1 (de)	1995-06-08
ES2071725T3 (es)	1995-07-01
EP0430045A2 (en)	1991-06-05
JP2854631B2 (ja)	1999-02-03
ATE121939T1 (de)	1995-05-15
EP0430045B1 (en)	1995-05-03
DE69019111T2 (de)	1995-08-31
CA2029420C (en)	2000-09-19
CA2029420A1 (en)	1991-05-22

Publication	Publication Date	Title
DK0430045T3 (da)	1995-07-17	Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
AU2118488A (en)	1989-02-23	Improvements in or relating to methods of treating damaged skin
PT83647A (en)	1986-11-01	Process for the preparation of novel pharmaceutical benzimidazole derivatives and of pharmaceutical compositions containing the same
EP0324387A3 (en)	1990-06-13	Composition for treatment of ischemic disorder in organs
DE69030616D1 (de)	1997-06-05	Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion
EP0321968A3 (en)	1990-10-31	Compounds active on the cardiovascular system
ES2111352T3 (es)	1998-03-01	Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ATE71092T1 (de)	1992-01-15	Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
PT85866A (en)	1987-11-01	Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
NZ228182A (en)	1990-08-28	Substituted 4,5,6,7-tetrahydroisothiazolo(4,5-c) pyridine derivatives and pharmaceutical compositions; methods for preparation
EP0446921A3 (en)	1992-01-29	Optically active alkylene-dioxybenzene derivatives and their use in therapy
ATE88176T1 (de)	1993-04-15	2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
LT2199B (lt)	1993-10-15	2-triazolidinono dariniu gavimo budas
GR3004095T3 (da)	1993-03-31
ATE81466T1 (de)	1992-10-15	Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
KR900016130A (ko)	1990-11-12	2-피리딜메틸티오 유도체 및 궤양 치료제
AU2013888A (en)	1989-02-02	Uricosuric composition
ATE81465T1 (de)	1992-10-15	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
EP0321967A3 (en)	1990-10-24	Compounds active on the cardiovascular system
TW360630B (en)	1999-06-11	A secoaporphine compounds on arrhythmia